Millions of travelers suffer from jet lag every year. And now Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) said one of its drugs successfully addressed the problem with hundreds of volunteers in a late-stage clinical trial.
{iframe}https://www.bizjournals.com/washington/news/2018/03/05/a-drug-for-jet-lag-a-d-c-drug-developer-says-it.html{/iframe}